Only in Titles

           Search results for: Mouse Anti-Human CD69 [+RPE-Cy5] Antibodies    

paperclip

#22551544   // Save this To Up

Transient lymphocyte decrease due to adhesion and migration following catumaxomab (anti-EpCAM x anti-CD3) treatment in vivo.

In patients, a transient decrease in peripheral blood lymphocyte counts was observed following intraperitoneal administration of the trifunctional monoclonal antibody catumaxomab (anti-human EpCAM x anti-human CD3). The aim of this study was to clarify the observed effect in a preclinical mouse model and to analyse the related mechanism of action in vitro.

2388 related Products with: Transient lymphocyte decrease due to adhesion and migration following catumaxomab (anti-EpCAM x anti-CD3) treatment in vivo.

Rabbit Anti-Human Toll In FDA Standard Frozen Tissu Mouse Anti-Human CD103 (I Goat Anti-Human TOM1L1 SR Goat Anti-Human Factor XI FDA Standard Frozen Tissu Goat Anti-Human Ku80 XRCC Oral squamous cell cancer Mouse Anti-Human CD103 (I Goat Anti-Human XBP1 TREB Goat Anti-Human TIA1, (in Goat Anti-Human HVEM TR2,

Related Pathways

paperclip

#11298141   // Save this To Up

Non FcR-binding murine antihuman CD3 monoclonal antibody is capable of productive TCR signalling and induces proliferation in the presence of costimulation.

CLB T3/4.A is a non FcR-binding CD3 mAb of the murine IgA isotype, which may be used as an alternative for the mitogenic OKT3 mAb in the treatment of acute cellular rejection after organ transplantation. We studied TCR signalling and T cell activation in response to T3/4.A in normal human PBMC in vitro. T3/4.A induced a rapid rise in free cytoplasmic Ca(2+), not different from the response to mitogenic CD3 mAb. However, protein tyrosine phosphorylation and, particularly, MAPK activation, were reduced as compared to mitogenic CD3 mAb. T3/4.A enhanced expression of both CD69 and CD25, but proliferation and detectable cytokine production did not occur. Addition of either CD28 mAb or IL-2 induced a strong proliferative response, which was accompanied by cytokine production. At higher mAb concentrations, T cell activation decreased, which correlated with TCR downmodulation. To exclude the possibility that activation by T3/4.A depends on interaction of murine IgA Fc with as yet unknown FcR, we showed that also with CD3 mAb F(ab')2 fragments upregulation of activation molecules occurred, as well as proliferation in the presence of costimulation. We conclude that the non FcR-binding murine IgA mAb T3/4.A acts as a partial agonist and leads to proliferation and cytokine production only in the presence of appropriate costimuli. These findings may explain the mitigated cytokine release syndrome observed in vivo with some nonmitogenic CD3 mAbs.

1504 related Products with: Non FcR-binding murine antihuman CD3 monoclonal antibody is capable of productive TCR signalling and induces proliferation in the presence of costimulation.

Mouse Anti-Insulin(1D4:) Mouse Anti-Insulin(1G11) Mouse Anti-Insulin(1D4:) anti-Diazepam Binding Inh anti-Diazepam Binding Inh Anti AGO2 Mouse, Monoclon Mouse Anti-Insulin(1D4:) Mouse Anti-Insulin(1G11) Mouse Anti-Insulin(1D4:) Mouse Anti-Insulin(1G11) Mouse Anti-Insulin(1D4:) HIV1 integrase antibody,

Related Pathways

  •  
  • No related Items